The Univsersity of Arizona

NIH Weekly Funding Opportunities and Policy Notices

Tuesday, June 27, 2017 - 9:55am
Notice NOT-AI-17-031 from the NIH Guide for Grants and Contracts
Tuesday, June 27, 2017 - 8:51am
Notice NOT-OD-17-082 from the NIH Guide for Grants and Contracts
Monday, June 26, 2017 - 9:50am
Funding Opportunity RFA-FD-17-013 from the NIH Guide for Grants and Contracts. The Food and Drug Administration (FDA) is announcing the availability of cooperative agreement funds for the support of a Funding Opportunity Announcement (FOA) entitled "Academic Development of a Training Program for Good Laboratory Practices in High Containment Environments (U24).' In this FOA, FDA announces its intention to accept and consider a single source application for an award to the University of Texas Medical Branch (UTMB) Galveston National Laboratory (GNL) for the development and implementation of a certified, academic training course for instruction in Good Laboratory Practices (GLP) in a Biosafety Level (BSL) 4 High Containment Environment. FDA seeks to support an effort to design a robust, collaborative, and educational program using problem-based learning techniques designed to bring researchers and regulators together to educate each other on the challenges related to these issues and to identify solutions that are acceptable from both scientific and regulatory perspectives.
Monday, June 26, 2017 - 9:40am
Funding Opportunity RFA-FD-17-014 from the NIH Guide for Grants and Contracts. The goals of this program are to support the development of the scientific infrastructure needed to plan and execute pediatric clinical trials through collaboration with stakeholders from academia, industry, parent/patient advocacy groups, and government agencies. The Global Pediatric Trial Network should be a coordinating resource for pediatric product development with sustainable global infrastructure to plan, start up, conduct, and close out pediatric clinical investigations. There should be an emphasis on operational efficiency and network sustainability with early, systematic, and integrative approaches to pediatric studies.
Monday, June 26, 2017 - 9:08am
Funding Opportunity RFA-AT-17-003 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA), issued by the National Center for Complementary and Integrative Health (NCCIH), seeks to solicit limited applications for continuation of an established research resource consisting of a database of primary reports of the full spectrum of complementary and integrative health controlled clinical trials. This resource will facilitate the conduct of high quality systematic reviews and when possible meta-analyses of published reports of clinical trials of complementary and integrative health treatments and interventions. The review of all published controlled clinical trials on a given topic and summary of the results in a systematic and unbiased manner provide a current best evidence for health care practitioners, patients, health care policy makers and research administration. In addition, the resource will ensure and promote access and availability to the broader scientific community and provide editorial, methodological and technical support to those utilizing the resource for systematic reviews. Applications must address the following: justification regarding why continued funding is needed from NIH; plans for maintenance of a research resource consisting of a complementary and integrative health controlled clinical trials database; plans to ensure access and availability of the resource to the scientific community; address updates of current reviews in the database; conduct of a minimum of one new and update two existing NCCIH strategic plan-related systematic reviews per year and when possible meta-analyses; and methods the investigators will use to identify new reviews and updates that align with NCCIH strategic priorities, particularly evaluating the effectiveness of mind and body complementary interventions for pain conditions.
Monday, June 26, 2017 - 8:00am
Funding Opportunity RFA-HG-17-006 from the NIH Guide for Grants and Contracts. The National Human Genome Research Institute (NHGRI) is soliciting grant applications for the support of Centers of Excellence in Ethical, Legal and Social Implications (ELSI) Research (CEERs). The CEER Program is designed to support the establishment of sustainable trans-disciplinary research teams with the expertise and flexibility to anticipate, conduct research on, and quickly address a range of cutting edge ethical, legal, and social issues related to genetics and genomics. The Program is intended to create new research opportunities that cross disciplinary boundaries among investigators in diverse fields, such as the genomic sciences, clinical research, clinical and health policy, ethics, law, the humanities, economics, political science, anthropology and other social sciences. In addition to conducting trans-disciplinary research, Centers will disseminate their research findings as well as facilitate the use of their findings to develop relevant research, health and public policies and practices. Finally, Centers will contribute to developing the next generation of ELSI researchers.
Friday, June 23, 2017 - 10:52am
Funding Opportunity PAR-17-322 from the NIH Guide for Grants and Contracts. The NEI Center Core Grant combines three or more Resource and/or Service Cores for a group of R01 investigators to enhance their research, consolidate resources, avoid duplication of efforts, and/or contribute to cost effectiveness by providing a service with lower costs or higher quality than could be attempted for independent projects by several individual Program Directors/Principal Investigators (PD(s)/PI(s)). Shared resources and facilities that are accessible to a group of independently funded investigators lead to greater productivity for the separate projects and can provide instrumentation and facilities that are too costly to be maintained by an individual investigator. The design and purpose of each Center Core may vary in how it serves its users. This program is designed to enhance an institution's environment and capability to conduct vision research and to facilitate collaborative studies of the visual system and its disorders.
Friday, June 23, 2017 - 10:25am
Notice NOT-OD-17-077 from the NIH Guide for Grants and Contracts
Friday, June 23, 2017 - 10:25am
Notice NOT-OD-17-078 from the NIH Guide for Grants and Contracts
Friday, June 23, 2017 - 10:25am
Notice NOT-OD-17-079 from the NIH Guide for Grants and Contracts
Friday, June 23, 2017 - 10:24am
Notice NOT-OD-17-080 from the NIH Guide for Grants and Contracts
Friday, June 23, 2017 - 10:24am
Notice NOT-OD-17-081 from the NIH Guide for Grants and Contracts
Friday, June 23, 2017 - 9:55am
Notice NOT-RM-17-031 from the NIH Guide for Grants and Contracts
Friday, June 23, 2017 - 9:52am
Notice NOT-HL-17-524 from the NIH Guide for Grants and Contracts
Friday, June 23, 2017 - 9:47am
Funding Opportunity PAR-17-320 from the NIH Guide for Grants and Contracts. This FOA encourages exploratory/developmental research applications at the intersection of HIV and aging by addressing two overarching objectives: 1) to improve understanding of biological, clinical, and socio-behavioral aspects of aging through the lens of HIV infection and its treatment; and 2) to improve approaches for testing, prevention, and treatment of HIV infection, and management of HIV-related comorbidities, co-infections, and complications in different populations and cultural settings by applying our current understanding of aging science. Applications appropriate to this FOA should be consistent with the scientific priorities outlined by the NIH Office of AIDS Research (OAR) as described in NOT-OD-15-137.
Friday, June 23, 2017 - 9:47am
Funding Opportunity PAR-17-321 from the NIH Guide for Grants and Contracts. This FOA encourages applications at the intersection of HIV and aging by addressing two overarching objectives: 1) to improve understanding of biological, clinical, and socio-behavioral aspects of aging through the lens of HIV infection and its treatment; and 2) to improve approaches for testing, prevention, and treatment of HIV infection, and management of HIV-related comorbidities, co-infections, and complications in different populations and cultural settings by applying our current understanding of aging science. Applications appropriate to this FOA should be consistent with the scientific priorities outlined by the NIH Office of AIDS Research (OAR) as described in NOT-OD-15-137.
Friday, June 23, 2017 - 9:07am
Funding Opportunity RFA-ES-17-007 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) solicits Small Business Innovative Research (SBIR) grant applications from small business concerns (SBCs) to develop medium- to high-throughput assays to evaluate the effects of toxicants on pluripotent or induced pluripotent cells with respect to cell differentiation and the resulting differentiated cell populations. The ability to incorporate genetic diversity in these assays would be useful. These assays will provide information on mechanisms of chemically-induced biological activity, help to prioritize chemicals for more extensive toxicological evaluation, support more predictive models of in vivo biological response, and potentially inform on the role of genetic diversity in toxicological effects.
Friday, June 23, 2017 - 8:23am
Notice NOT-OD-17-083 from the NIH Guide for Grants and Contracts

Pages